Biotech · Private company · Newark, DE, US
Koi Biotherapeutics Inc.
Track this companyFree. Adds Koi Biotherapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Revolutionizing CAR T-cell Therapy: Enhancing Activity and Persistence of CAR T-cell by Developing a CAR-Enhancer PlatformFiscal year 2026 · $703.6KNIH RePORTER 5R44CA298774-02 · fetched Nov 12, 2026
- Revolutionizing CAR T-cell Therapy: Enhancing Activity and Persistence of CAR T-cell by Developing a CAR-Enhancer PlatformFiscal year 2025 · $1.3MNIH RePORTER 1R44CA298774-01A1 · fetched Nov 12, 2026